ST宜化(000422.SZ)擬以債轉股的方式對貴州宜化增資5億元
格隆匯12月15日丨ST宜化(000422.SZ)公佈,貴州宜化化工有限責任公司(“貴州宜化”)為公司的全資子公司。為優化貴州宜化資產負債結構,改善貴州宜化的經營狀況,公司擬以債轉股的方式對貴州宜化增資5億元。此次增資不構成關聯交易。
由於貴州宜化自身債務負擔沉重,運營資金不足,近年來生產裝置低負荷運行,經營虧損嚴重,拖累公司經營業績,加重了公司的經營負擔。公司本次對貴州宜化增資,旨在改善貴州宜化的資產負債結構,為下一步處置貴州宜化資產、減輕公司的經營負擔創造條件。本次增資符合公司的整體利益和長遠利益,有利於公司健康、可持續發展。
Follow us
Find us on
Facebook,
Twitter ,
Instagram, and
YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the
uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!

Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.